Determining the Function of TRPC3 in Allergic Contact Dermatitis Induced Itch

确定 TRPC3 在过敏性接触性皮炎引起的瘙痒中的功能

基本信息

  • 批准号:
    9760106
  • 负责人:
  • 金额:
    $ 3.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

Project Summary The definition of itch as an irritating sensation that triggers the desire to scratch does not fully capture the impact on people suffering from acute and chronic itch (personal discomfort, inattention, insomnia, medical expenses, and lost work). Previous studies have highlighted the important role of TRP channels, such as TRPV1 and TRPA1, in a variety of sensory pathways including itch. In this proposal, I aim to provide a better understanding of the pathophysiology underlying itch by examining the role of the TRP channel, TRPC3, in a mouse model of allergic contact dermatitis. Previously published data from our lab found TrpC3 null mice exhibited no phenotypic differences in a variety of behavioral tests for acute pain and itch sensation. My preliminary behavioral studies have shown that TrpC3 knock out mice display greater scratching behavior in response to the mouse model of allergic contact dermatitis (ACD), termed contact hypersensitivity (CHS), when compared to wild type controls. Since TrpC3 is known to be expressed in dorsal root ganglion neurons, cholinergic neurons, glutamatergic neurons, and T cells, I hypothesize that TrpC3 antagonizes itch sensation through one of these cell types. In Aim 1, I will confirm the expression pattern of TrpC3 in the nervous system and immune system and determine whether changes in expression occur with CHS by utilizing real time PCR and in situ hybridization. Additionally, I will characterize the infiltration of immune cells in the affected skin of mice with CHS (TRPC3 KO and WT mice) through skin histology and flow cytometry. In Aim 2, I will determine whether TRPC3 modulates itch in ACD through its expression in neuronal and immune cells, using TrpC3 conditional KO mice. Specifically, I will create neuronal and immune cell TrpC3 conditional knock out mouse lines to determine which cell types require TrpC3 expression to suppress itch sensation in ACD under normal conditions by examining the scratching behavior. To target TrpC3 expression in neuronal cells, I will generate three TrpC3 conditional KO lines using Synapsin1Cre (all neurons), ChATiCre (cholinergic neurons), and VGLUT2Cre (glutamatergic neurons) genetic alleles. To target TrpC3 expression in immune cells, I will use the hematopoietic Cre line, Vav1-iCre drivers. Successful completion of the proposed aims will provide critical insight into the role of TRPC3 in antagonizing itch sensation in ACD and will propel further cellular and molecular studies to identify the pathophysiology of itch. The results of this project have the potential to impact treatment outcomes and is applicable to a significant portion of the population who suffer from ACD and chronic itch.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katherine Beattie其他文献

Katherine Beattie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
  • 批准号:
    10778757
  • 财政年份:
    2023
  • 资助金额:
    $ 3.21万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 3.21万
  • 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
  • 批准号:
    10783106
  • 财政年份:
    2023
  • 资助金额:
    $ 3.21万
  • 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
  • 批准号:
    10740796
  • 财政年份:
    2023
  • 资助金额:
    $ 3.21万
  • 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
  • 批准号:
    10599401
  • 财政年份:
    2022
  • 资助金额:
    $ 3.21万
  • 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
  • 批准号:
    575854-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
  • 批准号:
    467076
  • 财政年份:
    2021
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
  • 批准号:
    9979265
  • 财政年份:
    2020
  • 资助金额:
    $ 3.21万
  • 项目类别:
Endocannabinoid Metabolism in Acute Pain
急性疼痛中的内源性大麻素代谢
  • 批准号:
    10356880
  • 财政年份:
    2020
  • 资助金额:
    $ 3.21万
  • 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
  • 批准号:
    10218273
  • 财政年份:
    2020
  • 资助金额:
    $ 3.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了